Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells-Reference-Cited by-同舟云学术

Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells

Published:2019-09 Issue: Volume:47 Page:221-234
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Cornet-Masana Josep M.,Banús-Mulet Antònia,Carbó José M.,Torrente Miguel Ángel,Guijarro Francesca,Cuesta-Casanovas Laia,Esteve Jordi,Risueño Ruth M.^ORCID

Funder

Fundación Mutua Madrileña

CaixaImpulse

Spanish Ministry of Economy

Josep Carreras International Leukaemia Foundation

l'Obra Social “La Caixa”

Generalitat de Catalunya

Ramón y Cajal program

MINECO

Josep Carreras International Leukaemia Research Foundation

Obra Social La Caixa-Fundació Bancària La Caixa

CERCA Programme

Risueño Laboratory

Martí Duran-Ferrer

Advanced Optical Microscopy Unit

Ramón y Cajal program of the Spanish Ministry of Economy

l'Obra Social “La Caixa”-Fundació Bancària “La Caixa”

CERCA Programme/Generalitat de Catalunya

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference75 articles.

1. Classification and risk assessment in AML: integrating cytogenetics and molecular profiling;Moarii;Hematol Am Soc Hematol Educ Progr,2017

2. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing;Ding;Nature,2012

3. DNMT3A mutations in acute myeloid leukemia;Ley;N Engl J Med,2010

4. Recurring mutations found by sequencing an acute myeloid leukemia genome;Mardis;N Engl J Med,2009

5. The origin and evolution of mutations in acute myeloid leukemia;Welch;Cell,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics and pharmacological characterization of patient-derived glioma cell lines;Nature Communications;2024-08-08

2. Repositioning the antihistamine ebastine as an intracellular siRNA delivery enhancer;International Journal of Pharmaceutics;2023-09

3. A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia;Cancers;2023-03-22

4. Multi-omics and Pharmacological Characterization of Patient-derived Glioma Cell Lines;2023-02-21

5. Lysosomes as a Target of Anticancer Therapy;International Journal of Molecular Sciences;2023-01-22